Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction

European Journal of Clinical Investigation

Volumn 38, Issue 12, 2008, Pages 925-930

  Malecki, M T ^a   Osmenda, G ^a   Walus Miarka, M ^a   Skupien, J ^a   Cyganek, K ^a   Mirkiewicz Sieradzka, B ^a   Damek Guzik, T A ^a   Guzik, T J ^a   Sieradzki, J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; Endothelium; Retinopathy; Type 2 diabetes mellitus

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGY; PRIORITY JOURNAL; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VON WILLEBRAND FACTOR;

EID: 56649091048     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02051.x     Document Type: Article

References (32)

1. Jönsson B, CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia 2002 45 : S5 12.
2. Hiller R, Sperduto RD, Podgor MJ, Ferris FL 3rd, Wilson PW. Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 1988 28 : 402 9.
3. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000 321 : 412 9.
4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 : 405 12.
5. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörä là K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996 19 : 1445 8.
6. Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002 25 : 2032 6.
7. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients: the Valpolicella Heart Diabetes Study. Diabetes Care 2006 29 : 1178.
8. van Hecke MV, Dekker JM, Nijpels G, Stolk RP, Henry RM, Heine RJ et al. Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The Hoorn Study. Clin Sci (Lond) 2006 110 : 597 604.
9. Juutilainen A, Lehto S, Rönnemaa T, Pyörälà K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007 30 : 292 9.
10. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med 2008 25 : 45 50.
11. Csiba L. Endothelial function testing. Front Neurol Neurosci 2006 21 : 27 35.
12. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004 9 : 1118 35.
13. Hayoz D, Mazzolai L. Endothelial function, mechanical stress and atherosclerosis. Adv Cardiol 2007 44 : 62 75.
14. Avogaro A, Fadini GP, Gallo A, Pagnin E, de Kreutzenberg S. Endothelial dysfunction in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2006 16 (Suppl. 1 S39 45.
15. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005 109 : 143 59.
16. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002 346 : 1145 51.
17. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002 146 : 695 9.
18. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986 74 : 1399 406.
19. Mancini GB, Dahlöf B, Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004 109 (25 Suppl. 1 IV22 30.
20. Malecki MT, Undas A, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow P, Osmenda G et al. Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes. Diabetes Care 2007 30 : 2899 901.
21. Aldington S, Kohner E, Meuer S, Klein R, Sjolie A. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications study. Diabetologia 1995 38 : 437 44.
22. Rema M, Mohan V, Deepa R, Ravikumar R Chennai Urban Rural Epidemiology Study-2. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004 27 : 1962 7.
23. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007 30 : 1742 6.
24. van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005 28 : 1383 1389.
25. Nair BM, Viswanathan V, Snehalatha C, Mohan RS, Ramachandran A. Flow mediated dilatation and carotid intimal media thickness in South Indian type 2 diabetic subjects. Diabetes Res Clin Pract 2004 65 : 13 9.
26. Suetsugu M, Takebayashi K, Aso Y. Association between diabetic microangiopathy and vascular endothelial function evaluated by flow-mediated vasodilatation in patients with type 2 diabetes. Int J Clin Pract 2007 61 : 920 6.
27. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995 18 : 87 9.
28. Siemianowicz K, Francuz T, Gminski J, Telega A, Syzdól M. Endothelium dysfunction markers in patients with diabetic retinopathy. Int J Mol Med 2005 15 : 459 62.
29. Meleth AD, Agrón E, Chan CC, Reed GF, Arora K, Byrnes G et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005 46 : 4295 301.
30. Matsumoto K, Sera Y, Ueki Y, Inukai G, Niiro E, Miyake S. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med 2002 19 : 822 6.
31. van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005 48 : 1300 6.
32. De Mattia G, Bravi MC, Laurenti O, Moretti A, Cipriani R, Gatti A et al. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. Diabetes Res Clin Pract 2008 79 : 337 42.